Gamida Cell is building a pipeline of curative cellular and immune treatments for cancer and orphan genetic diseases.

One Technology:
Many Applications

Gamida Cell’s pipeline of products is based on the company’s proprietary NAM technology which increases the population of functional cells in culture.

This technology is being applied to various cell types, to develop a pipeline of curative treatments for a wide range of conditions including cancer, genetic hematological diseases such as sickle cell disease and thalassemia, bone marrow failure syndromes such as aplastic anemia and genetic metabolic diseases.